临床前DNA疫苗接种的最新进展
Recent Developments in Preclinical DNA Vaccination.
作者信息
Okuda Kenji, Wada Yoshiyuki, Shimada Masaru
机构信息
Department of Molecular Biodefense Research, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa Prefecture 236-0004, Japan.
Choju Medical Institute, Toyohashi, Aichi Prefecture 441-8124, Japan.
出版信息
Vaccines (Basel). 2014 Jan 13;2(1):89-106. doi: 10.3390/vaccines2010089.
Abstract
The advantages of genetic immunization of the new vaccine using plasmid DNAs are multifold. For example, it is easy to generate plasmid DNAs, increase their dose during the manufacturing process, and sterilize them. Furthermore, they can be stored for a long period of time upon stabilization, and their protein encoding sequences can be easily modified by employing various DNA-manipulation techniques. Although DNA vaccinations strongly increase Th1-mediated immune responses in animals, several problems persist. One is about their weak immunogenicity in humans. To overcome this problem, various genetic adjuvants, electroporation, and prime-boost methods have been developed preclinically, which are reviewed here.
摘要
使用质粒DNA进行新型疫苗基因免疫的优势是多方面的。例如，质粒DNA易于制备，在生产过程中可以增加其剂量，并且能够进行灭菌处理。此外，经稳定化处理后它们可以长期保存，而且通过各种DNA操作技术可以轻松修改其蛋白质编码序列。尽管DNA疫苗接种能在动物体内强烈增强Th1介导的免疫反应，但仍存在一些问题。其中之一是它们在人体内的免疫原性较弱。为克服这一问题，临床前已开发出各种基因佐剂、电穿孔法和初免-加强免疫方法，本文对此进行综述。
相似文献
1
Recent Developments in Preclinical DNA Vaccination.临床前DNA疫苗接种的最新进展
Vaccines (Basel). 2014 Jan 13;2(1):89-106. doi: 10.3390/vaccines2010089.
2
Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.电穿孔作为一种针对肿瘤抗原的裸DNA疫苗接种的“初免/加强”策略。
J Immunol. 2005 May 15;174(10):6292-8. doi: 10.4049/jimmunol.174.10.6292.
3
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8 T-Cell Responses by Interleukin-12 Plasmid DNA.DNA 启动可增加对水疱性口炎病毒 HIV 疫苗的 T 细胞应答频率，白细胞介素 -12 质粒 DNA 可特异性增强 CD8 T 细胞应答。
Clin Vaccine Immunol. 2017 Nov 6;24(11). doi: 10.1128/CVI.00263-17. Print 2017 Nov.
4
Plasmid DNA vaccines: where are we now?质粒DNA疫苗：我们目前处于什么阶段？
Drugs Today (Barc). 2018 May;54(5):315-333. doi: 10.1358/dot.2018.54.5.2807864.
5
Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.用表达白细胞介素-12和猿猴免疫缺陷病毒gag的质粒DNA进行预刺激，可增强基于重组水疱性口炎病毒的实验性艾滋病疫苗的免疫原性和效力。
AIDS Res Hum Retroviruses. 2005 Jul;21(7):629-43. doi: 10.1089/aid.2005.21.629.
6
The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice.基因佐剂白细胞介素-12 和粒细胞-巨噬细胞集落刺激因子增强了埃博拉病毒 DNA 疫苗在小鼠中的免疫原性。
J Infect Dis. 2018 Nov 22;218(suppl_5):S519-S527. doi: 10.1093/infdis/jiy378.
7
Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.弓形虫 GRA14 的 DNA 初免和重组蛋白加强免疫诱导的保护效力。
Microb Pathog. 2019 Sep;134:103601. doi: 10.1016/j.micpath.2019.103601. Epub 2019 Jun 15.
8
Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.通过皮内电穿孔法延迟给予质粒DNA可有效增强DNA启动的针对癌胚抗原的T细胞和B细胞反应。
Vaccine. 2009 Jun 8;27(28):3692-6. doi: 10.1016/j.vaccine.2009.04.013. Epub 2009 May 3.
9
In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.在DNA-病毒样颗粒初免-加强免疫中进行体内电穿孔可优先增强HIV-1包膜特异性IgG2a、中和抗体及CD8 T细胞反应。
Vaccine. 2017 Apr 11;35(16):2042-2051. doi: 10.1016/j.vaccine.2017.03.006. Epub 2017 Mar 17.
10
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.一项 I 期双盲、安慰剂对照、随机研究，评估电穿孔 HIV DNA 联合或不联合白细胞介素 12 佐剂，与 Ad35 HIV 疫苗在初免-加强免疫组合中的安全性和免疫原性，该研究纳入了健康的 HIV 血清阴性非洲成年人。
PLoS One. 2015 Aug 7;10(8):e0134287. doi: 10.1371/journal.pone.0134287. eCollection 2015.
引用本文的文献
1
Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis-induced injury.ag85a/b DNA 疫苗的作用机制可实现免疫治疗并从结核分枝杆菌引起的损伤中恢复。
Immun Inflamm Dis. 2023 May;11(5):e854. doi: 10.1002/iid3.854.
2
Evaluation of Triple Fragment Vaccine HSPX ( + PPE44 () + Mouse IgG ( with Auxiliary Adjuncts IL-22 in Comparison with BCG Vaccine.三联片段疫苗HSPX（+PPE44（）+小鼠IgG（）与卡介苗相比，联合辅助剂IL-22的评估。 （注：原文括号部分表述不太清晰准确，可能影响理解）
Iran J Pathol. 2022 Summer;17(3):303-313. doi: 10.30699/IJP.2022.549673.2849. Epub 2022 Aug 13.
3
Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis.揭示非小细胞肺癌的潜在关键基因、治疗靶点和药物：来自综合生物信息学分析的证据
Vaccines (Basel). 2022 May 12;10(5):771. doi: 10.3390/vaccines10050771.
4
Bacteria and cells as alternative nano-carriers for biomedical applications.细菌和细胞作为生物医学应用的替代纳米载体。
Expert Opin Drug Deliv. 2022 Jan;19(1):103-118. doi: 10.1080/17425247.2022.2029844. Epub 2022 Jan 25.
5
Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.表达克里米亚-刚果出血热病毒核蛋白的基于DNA的辛德毕斯复制子的免疫原性
Vaccines (Basel). 2021 Dec 16;9(12):1491. doi: 10.3390/vaccines9121491.
6
SARS-CoV-2 vaccine candidates in rapid development.正在快速开发的 SARS-CoV-2 疫苗候选物。
Hum Vaccin Immunother. 2021 Mar 4;17(3):644-653. doi: 10.1080/21645515.2020.1804777. Epub 2020 Oct 29.
7
Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine.内质网靶向序列增强了基于肿瘤相关抗原L6的DNA疫苗的细胞免疫。
Am J Cancer Res. 2019 Sep 1;9(9):2028-2036. eCollection 2019.
8
Current trends in targeted therapy for drug-resistant infections.耐药感染的靶向治疗的当前趋势。
Appl Microbiol Biotechnol. 2019 Oct;103(20):8301-8314. doi: 10.1007/s00253-019-10028-5. Epub 2019 Aug 14.
9
Recent trends and advances in microbe-based drug delivery systems.基于微生物的药物传递系统的最新趋势和进展。
Daru. 2019 Dec;27(2):799-809. doi: 10.1007/s40199-019-00291-2. Epub 2019 Aug 2.
10
Antitumor Effects of HPV DNA Vaccine Adjuvanted with Beclin-1 as an Autophagy Inducer in a Mice Model.以自噬诱导剂Beclin-1为佐剂的HPV DNA疫苗在小鼠模型中的抗肿瘤作用
Iran Biomed J. 2019 Nov;23(6):388-94. doi: 10.29252/ibj.23.6.388. Epub 2019 May 20.
本文引用的文献
1
Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.用重组 RNA 复制子颗粒免疫接种可保护鸡免受 H5N1 高致病性禽流感病毒的侵害。
PLoS One. 2013 Jun 10;8(6):e66059. doi: 10.1371/journal.pone.0066059. Print 2013.
2
Replication and transcription activities of ribonucleoprotein complexes reconstituted from avian H5N1, H1N1pdm09 and H3N2 influenza A viruses.由禽流感H5N1、甲型H1N1pdm09和H3N2流感病毒重组的核糖核蛋白复合物的复制和转录活性。
PLoS One. 2013 Jun 4;8(6):e65038. doi: 10.1371/journal.pone.0065038. Print 2013.
3
Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease.活性DNA Aβ42疫苗接种作为阿尔茨海默病的免疫疗法
Transl Neurosci. 2012 Dec 1;3(4):307-313. doi: 10.2478/s13380-012-0037-6.
4
Recent advances towards the clinical application of DNA vaccines.DNA疫苗临床应用的最新进展。
Neth J Med. 2013 Apr;71(3):109-17.
5
Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.DNA 和腺病毒载体的联合免疫可预防同时感染乙型肝炎病毒和土拨鼠肝炎病毒后感染丁型肝炎病毒（HDV）。
J Virol. 2013 Jul;87(13):7708-16. doi: 10.1128/JVI.00645-13. Epub 2013 May 1.
6
PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice.基于 PD1 的 DNA 疫苗可在小鼠中扩增 HIV-1 GAG 特异性 CD8+ T 细胞。
J Clin Invest. 2013 Jun;123(6):2629-42. doi: 10.1172/JCI64704. Epub 2013 May 1.
7
DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial.无针注射装置递送的 DNA 疫苗可提高经 rAd5 加强后针对抗体和 CD8+ T 细胞应答的初免效力：一项随机临床试验。
PLoS One. 2013;8(4):e59340. doi: 10.1371/journal.pone.0059340. Epub 2013 Apr 8.
8
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.DNA 疫苗/腺病毒增强型疟疾疫苗编码 PfCSP 和 AMA1 诱导与细胞免疫相关的无疟疾保护作用。
PLoS One. 2013;8(2):e55571. doi: 10.1371/journal.pone.0055571. Epub 2013 Feb 14.
9
CpG oligodeoxynucleotide induces apoptosis and cell cycle arrest in A20 lymphoma cells via TLR9-mediated pathways.CpG 寡脱氧核苷酸通过 TLR9 介导的途径诱导 A20 淋巴瘤细胞凋亡和细胞周期停滞。
Mol Immunol. 2013 Jul;54(3-4):327-37. doi: 10.1016/j.molimm.2013.01.001. Epub 2013 Jan 26.
10
Polymer multilayer tattooing for enhanced DNA vaccination.聚合物多层纹身增强 DNA 疫苗接种。
Nat Mater. 2013 Apr;12(4):367-76. doi: 10.1038/nmat3550. Epub 2013 Jan 27.
Zotero 插件